Release Date: 01/05/13 08:22 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 44.61KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%